Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of three insulin intensification regimens in type 2 diabetes mellitus
ChiCTR-TRC-11001218Phase 4Completed
- Sponsor
- Nanjing First Hospital
- Start
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin aspart, insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Nanjing First Hospital. Started Jan 2010; status: completed.
02
Drugs
insulin aspartinsulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-11001218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001218.